Co-treatment of erythroid cells from -thalassemia patients with crispr-cas9-based 039-globin gene editing and induction of fetal hemoglobin

HIGHLIGHTS

• who: Lucia Carmela Cosenza et al. from the Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, Ferrara, Italy have published the Article: Co-Treatment of Erythroid Cells from -Thalassemia Patients with CRISPR-Cas9-Based 039-Globin Gene Editing and Induction of Fetal Hemoglobin, in the Journal: Genes 2022, 1727 of /2022/
• what: The aim of the study was to verify whether the de novo production of adult hemoglobin (HbA) using gene editing can be combined with HbF induction protocols. Of great interest is the fact that this strategy . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.